You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Diabetes Articles
Popular Diabetes Articles
Highly Recommended Diabetes Articles
Send a link to this page to your friends and colleagues.
Heralded as the best thing since insulin, pramilitide, a new drug being studied by two U.S. research centers, may soon be available to help type 1 individuals reduce hypoglycemia risks. The St. James Center for Diabetes in Chicago and Tulane University Medical Center in New Orleans both recently launched studies of the drug's effectiveness in improving glucose control and lessening the risk of hypoglycemia in type 1 patients. In preliminary studies, patients not only improved glucose control while using pramilitide, but had better cholesterol profiles and lost weight. The current studies seek to confirm the earlier findings.
Both the St. James Center and Tulane University are currently seeking candidates to participate in their studies. Participants must have been taking insulin for at least 12 months, be in good health, have had a stable insulin regimen for the past two months, and be willing to take additional injections of the experimental drug as an adjunct to insulin.
Contact Robyn Ekings in New Orleans at (504) 588-5221 or Christine Beebe in Chicago at (708) 709-2010 for more information.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.